CN Patent

CN115368358A — 一种Sotorasib新晶型及其制备方法与应用

Assigned to Zhejiang Jiuzhou Pharmaceutical Co Ltd · Expires 2022-11-22 · 3y expired

What this patent protects

本发明属于医药技术领域，具体说是Sotorasib的新晶型及其制备方法与应用，该新晶型为Sotorasib的乙酸溶剂化物，化学性质稳定，容易保存，适合制成各种制剂。并且制备过程简单易行，适合工业化生产，为Sotorasib制剂开发提供了新的选择。

USPTO Abstract

本发明属于医药技术领域，具体说是Sotorasib的新晶型及其制备方法与应用，该新晶型为Sotorasib的乙酸溶剂化物，化学性质稳定，容易保存，适合制成各种制剂。并且制备过程简单易行，适合工业化生产，为Sotorasib制剂开发提供了新的选择。

Drugs covered by this patent

Patent Metadata

Patent number
CN115368358A
Jurisdiction
CN
Classification
—
Expires
2022-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.